FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381617692> ?p ?o ?g. }

• W4381617692 endingPage "1790" @default.
• W4381617692 startingPage "1790" @default.
• W4381617692 abstract "Reperfusion injuries after a period of cardiac ischemia are known to lead to pathological modifications or even death. Among the different therapeutic options proposed, adenosine, a small molecule with platelet anti-aggregate and anti-inflammatory properties, has shown encouraging results in clinical trials. However, its clinical use is severely limited because of its very short half-life in the bloodstream. To overcome this limitation, we have proposed a strategy to encapsulate adenosine in squalene-based nanoparticles (NPs), a biocompatible and biodegradable lipid. Thus, the aim of this study was to assess, whether squalene-based nanoparticles loaded with adenosine (SQAd NPs) were cardioprotective in a preclinical cardiac ischemia/reperfusion model. Obtained SQAd NPs were characterized in depth and further evaluated in vitro. The NPs were formulated with a size of about 90 nm and remained stable up to 14 days at both 4 °C and room temperature. Moreover, these NPs did not show any signs of toxicity, neither on HL-1, H9c2 cardiac cell lines, nor on human PBMC and, further retained their inhibitory platelet aggregation properties. In a mouse model with experimental cardiac ischemia-reperfusion, treatment with SQAd NPs showed a reduction of the area at risk, as well as of the infarct area, although not statistically significant. However, we noted a significant reduction of apoptotic cells on cardiac tissue from animals treated with the NPs. Further studies would be interesting to understand how and through which mechanisms these nanoparticles act on cardiac cells." @default.
• W4381617692 created "2023-06-23" @default.
• W4381617692 creator A5003374394 @default.
• W4381617692 creator A5007011054 @default.
• W4381617692 creator A5009454596 @default.
• W4381617692 creator A5020726934 @default.
• W4381617692 creator A5026148573 @default.
• W4381617692 creator A5030622352 @default.
• W4381617692 creator A5034493531 @default.
• W4381617692 creator A5038117884 @default.
• W4381617692 creator A5057807678 @default.
• W4381617692 creator A5060333382 @default.
• W4381617692 creator A5078174247 @default.
• W4381617692 creator A5089635381 @default.
• W4381617692 creator A5092234288 @default.
• W4381617692 date "2023-06-21" @default.
• W4381617692 modified "2023-10-14" @default.
• W4381617692 title "Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion" @default.
• W4381617692 cites W1510017290 @default.
• W4381617692 cites W1880563629 @default.
• W4381617692 cites W1893143839 @default.
• W4381617692 cites W1994446230 @default.
• W4381617692 cites W1995192682 @default.
• W4381617692 cites W2021917695 @default.
• W4381617692 cites W2022159206 @default.
• W4381617692 cites W2023570654 @default.
• W4381617692 cites W2030609959 @default.
• W4381617692 cites W2039193465 @default.
• W4381617692 cites W2048350889 @default.
• W4381617692 cites W2053124932 @default.
• W4381617692 cites W2053694215 @default.
• W4381617692 cites W2055785937 @default.
• W4381617692 cites W2059055438 @default.
• W4381617692 cites W2063919290 @default.
• W4381617692 cites W2076446257 @default.
• W4381617692 cites W2086423357 @default.
• W4381617692 cites W2090368102 @default.
• W4381617692 cites W2094657005 @default.
• W4381617692 cites W2099891452 @default.
• W4381617692 cites W2100947498 @default.
• W4381617692 cites W2104481071 @default.
• W4381617692 cites W2114611409 @default.
• W4381617692 cites W2114675295 @default.
• W4381617692 cites W2114712140 @default.
• W4381617692 cites W2137442910 @default.
• W4381617692 cites W2148778286 @default.
• W4381617692 cites W2153712630 @default.
• W4381617692 cites W2162371193 @default.
• W4381617692 cites W2259130379 @default.
• W4381617692 cites W2290097313 @default.
• W4381617692 cites W2591053022 @default.
• W4381617692 cites W2892112375 @default.
• W4381617692 cites W2898326074 @default.
• W4381617692 cites W2913941327 @default.
• W4381617692 cites W2917794645 @default.
• W4381617692 cites W2919288695 @default.
• W4381617692 cites W2920831650 @default.
• W4381617692 cites W2954437208 @default.
• W4381617692 cites W2983278329 @default.
• W4381617692 cites W3119973110 @default.
• W4381617692 cites W3154454711 @default.
• W4381617692 cites W3158055798 @default.
• W4381617692 cites W3199190709 @default.
• W4381617692 cites W4205647138 @default.
• W4381617692 cites W4206168273 @default.
• W4381617692 cites W4206703572 @default.
• W4381617692 cites W4224307786 @default.
• W4381617692 cites W4280526603 @default.
• W4381617692 doi "https://doi.org/10.3390/pharmaceutics15071790" @default.
• W4381617692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37513977" @default.
• W4381617692 hasPublicationYear "2023" @default.
• W4381617692 type Work @default.
• W4381617692 citedByCount "0" @default.
• W4381617692 crossrefType "journal-article" @default.
• W4381617692 hasAuthorship W4381617692A5003374394 @default.
• W4381617692 hasAuthorship W4381617692A5007011054 @default.
• W4381617692 hasAuthorship W4381617692A5009454596 @default.
• W4381617692 hasAuthorship W4381617692A5020726934 @default.
• W4381617692 hasAuthorship W4381617692A5026148573 @default.
• W4381617692 hasAuthorship W4381617692A5030622352 @default.
• W4381617692 hasAuthorship W4381617692A5034493531 @default.
• W4381617692 hasAuthorship W4381617692A5038117884 @default.
• W4381617692 hasAuthorship W4381617692A5057807678 @default.
• W4381617692 hasAuthorship W4381617692A5060333382 @default.
• W4381617692 hasAuthorship W4381617692A5078174247 @default.
• W4381617692 hasAuthorship W4381617692A5089635381 @default.
• W4381617692 hasAuthorship W4381617692A5092234288 @default.
• W4381617692 hasBestOaLocation W43816176921 @default.
• W4381617692 hasConcept C126322002 @default.
• W4381617692 hasConcept C150903083 @default.
• W4381617692 hasConcept C164705383 @default.
• W4381617692 hasConcept C185592680 @default.
• W4381617692 hasConcept C202751555 @default.
• W4381617692 hasConcept C207001950 @default.
• W4381617692 hasConcept C2776703722 @default.
• W4381617692 hasConcept C2776991684 @default.
• W4381617692 hasConcept C541997718 @default.
• W4381617692 hasConcept C55493867 @default.

• next